dabigatran has been researched along with Atheroma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, MH; Wang, V; Wu, BC | 1 |
| Guo, JQ; Ji, JJ; Ma, GS; Qian, LL; Wu, YP; Yao, YY | 1 |
| Chevalier, P; Chinezu, L; Dobreanu, D; Fișcă, PC; Gheban, D; Gherțescu, D; Huțanu, A; Mărginean, A; Perian, M; Scridon, A; Șerban, RC; Vântu, A | 1 |
| Biessen, EA; Borissoff, JI; Daemen, MJ; Degen, JL; Esmon, CT; Hackeng, TM; Hamulyák, K; Heeneman, S; Leenders, P; Loubele, ST; Otten, JJ; Soehnlein, O; Spronk, HM; ten Cate, H; van Oerle, R; van Ryn, J; Weiler, H | 1 |
| Baumhäkel, M; Böhm, M; Kratz, MT; Lee, IO; Schirmer, SH | 1 |
5 other study(ies) available for dabigatran and Atheroma
| Article | Year |
|---|---|
The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Carotid Artery Thrombosis; Carotid Artery, Internal; Dabigatran; Female; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Middle Aged; Plaque, Atherosclerotic; Sigmoid Neoplasms; Thrombolytic Therapy; Tissue Plasminogen Activator | 2020 |
Protective role of serpina3c as a novel thrombin inhibitor against atherosclerosis in mice.
Topics: Animals; Antithrombins; Aorta; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Dabigatran; Diet, High-Fat; Male; Mice, Inbred C57BL; Mice, Knockout; Neointima; Plaque, Atherosclerotic; Serpins; Signal Transduction; Thrombin | 2021 |
Vascular protease-activated receptor 4 upregulation, increased platelet aggregation, and coronary lipid deposits induced by long-term dabigatran administration - results from a diabetes animal model.
Topics: Animals; Antithrombins; Aorta; Atherosclerosis; Coronary Vessels; Dabigatran; Diabetes Mellitus, Experimental; Drug Administration Schedule; Lipid Metabolism; Male; Plaque, Atherosclerotic; Platelet Aggregation; Rats, Wistar; Receptors, Thrombin; Time Factors; Up-Regulation | 2019 |
Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Benzimidazoles; Blood Coagulation; Dabigatran; Disease Models, Animal; Disease Progression; Female; Hematopoiesis; Inflammation; Mice; Mice, Knockout; Neutrophils; Phenotype; Plaque, Atherosclerotic; Pyridines; Reactive Oxygen Species; Thrombin; Thrombosis | 2013 |
The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.
Topics: Animals; Antithrombins; Apolipoproteins E; Benzimidazoles; beta-Alanine; Blood Pressure; Body Weight; Collagen; Dabigatran; Endothelium, Vascular; Ethidium; Fluorescent Dyes; Heart Rate; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Oxidative Stress; Plaque, Atherosclerotic; Thrombin | 2012 |